IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 49 filers reported holding IVERIC BIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $897,000 | -53.4% | 50,000 | -75.0% | 0.53% | -52.7% |
| Q2 2022 | $1,924,000 | -69.1% | 200,000 | -45.9% | 1.11% | -62.2% |
| Q1 2022 | $6,227,000 | +65.5% | 370,000 | +64.4% | 2.95% | +90.4% |
| Q4 2021 | $3,762,000 | -7.3% | 225,000 | -10.0% | 1.55% | +20.7% |
| Q3 2021 | $4,060,000 | +60.9% | 250,000 | -37.5% | 1.28% | +79.3% |
| Q2 2021 | $2,524,000 | -29.0% | 400,000 | -30.4% | 0.72% | -1.9% |
| Q1 2021 | $3,554,000 | -38.9% | 575,000 | -32.4% | 0.73% | -39.8% |
| Q4 2020 | $5,814,000 | +14.5% | 850,000 | -5.6% | 1.21% | -22.6% |
| Q3 2020 | $5,076,000 | -0.5% | 900,000 | -10.0% | 1.56% | +10.1% |
| Q2 2020 | $5,100,000 | +18.6% | 1,000,000 | -20.0% | 1.42% | -12.8% |
| Q1 2020 | $4,300,000 | -80.1% | 1,250,000 | -52.8% | 1.63% | -67.0% |
| Q4 2019 | $21,571,000 | +542.0% | 2,650,000 | -11.7% | 4.93% | +463.3% |
| Q3 2019 | $3,360,000 | -9.7% | 3,000,000 | 0.0% | 0.88% | -22.6% |
| Q2 2019 | $3,720,000 | – | 3,000,000 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |